vfend

Generic: voriconazole

Labeler: roerig
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vfend
Generic Name voriconazole
Labeler roerig
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

voriconazole 50 mg/1

Manufacturer
Roerig

Identifiers & Regulatory

Product NDC 0049-3170
Product ID 0049-3170_cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021266
Marketing Start 2003-03-28
Marketing End 2026-06-30

Pharmacologic Class

Established (EPC)
azole antifungal [epc]
Mechanism of Action
cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 2c9 inhibitors [moa]
Chemical Structure
azoles [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00493170
Hyphenated Format 0049-3170

Supplemental Identifiers

RxCUI
349434 349435 351209 352218 352219 352220 465355 546624
UNII
JFU09I87TR
NUI
N0000175487 M0002083 N0000182141 N0000182140 N0000185504

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vfend (source: ndc)
Generic Name voriconazole (source: ndc)
Application Number NDA021266 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (0049-3170-30)
source: ndc

Packages (1)

Ingredients (1)

voriconazole (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["349434", "349435", "351209", "352218", "352219", "352220", "465355", "546624"], "spl_set_id": ["ce3ef5cf-3087-4d92-9d94-9eb8287228db"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Roerig"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0049-3170-30)", "package_ndc": "0049-3170-30", "marketing_end_date": "20260630", "marketing_start_date": "20030328"}], "brand_name": "VFEND", "product_id": "0049-3170_cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "0049-3170", "generic_name": "voriconazole", "labeler_name": "Roerig", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VFEND", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "50 mg/1"}], "application_number": "NDA021266", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20030328"}